EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

EEDGAR/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice. EDGAR is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. EDGAR/calls is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›BOC

BOC

BOSTON OMAHA Corp

Next earnings Aug 11, 2026 · consensus $-0.03 EPS, $28.5M rev

Last earnings +3.2% on 2026-05-14

Sell
$13.57
▲ +4.06%
$13.57▼ -3.14%
over 1Y
L $11.06EODHDH $14.45
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+4.1%
1W+3.1%
1M+7.8%
3M+15.2%
YTD+7.9%
1Y-3.1%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Sell
Quality
C-
Valuation
Fair value
Filings
Flagged
Sell
Conviction
Horizon
Medium (3–12mo)
Street · 8 analysts
Sell

Revenue grew 5.6% YoY; but unprofitable (net margin -10.9%).

Revenue (FY2025) $114M · FY2025

BOSTON OMAHA Corp shows $114M in FY2025 revenue (+5.6% YoY), a -10.9% net margin, and -2.4% ROE.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$57.0M$81.2M$96.3M$108M$114M
Gross profit$38.4M$54.5M$64.4M$73.9M$75.3M
Operating income-$23.8M-$5.23M-$8.85M-$8.47M-$3.93M
Net income$52.7M$10.2M-$7.00M-$1.29M-$12.4M
Diluted EPS$1.82$0.34-$0.23-$0.04-$0.40
Net margin92.6%12.6%-7.3%-1.2%-10.9%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$45.5M
EV / EBITDA2.9
EV / Sales0.4
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-49.0%
FCF yield-39.6%

Quality & risk

ROIC (est.)-0.5%
Free cash flow-$10.0M
Total debt$48.8M
Net cash-$20.1M
Altman Z-Score0.29 distress
Piotroski F-Score4/9

Capital returns

Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+0.0%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Red flag in recent filings — restated periodic report (2026-04-30). Worth a closer look.
  1. 8-K New financial obligation2026-06-15
  2. 8-K Material agreement2026-05-18
  3. 8-K Earnings results2026-05-14
  4. 10-Q Quarterly report2026-05-14
  5. 10-K/A Restated periodic report2026-04-30
  6. 8-K Reg FD disclosure2026-03-31
  7. 8-K Reg FD disclosure2026-03-31
  8. 10-K Annual report2026-03-30
  9. 8-K Officer / director change2026-03-12

Recent filings

all on EDGAR ↗
8-KPeriod ending 2026-06-092026-06-15open ↗4Period ending 2026-05-282026-06-01open ↗4Period ending 2026-05-222026-05-27open ↗8-KPeriod ending 2026-05-182026-05-18open ↗8-KPeriod ending 2026-05-142026-05-14open ↗10-QPeriod ending 2026-03-312026-05-14open ↗10-K/APeriod ending 2025-12-312026-04-30open ↗SCHEDULE 13GFiling2026-04-27open ↗SCHEDULE 13D/AFiling2026-04-08open ↗4Period ending 2026-04-062026-04-08open ↗8-KPeriod ending 2026-03-302026-03-31open ↗8-KPeriod ending 2026-03-302026-03-31open ↗

Quality score

C-
ValueGrowthProfitHealthMom.
ValueA+
GrowthF
ProfitabilityF
Financial healthB-
Momentum—
  • ✓Revenue growing year-over-year
  • ✗Profitable (positive net income)
  • ✗Net margin above 10%
  • ✗Return on equity above 15%
  • ✓Liabilities below 2× equity
Revenue
$114M
+5.6% YoY
Net margin
-10.9%
ROE
-2.4%
P/E
—

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$114M+5.6%
Net income-$12.4M-861.5%
Gross profit$75.3M+1.9%
Operating income-$3.93M+53.6%
Diluted EPS-$0.40-900.0%
Cash & equivalents$28.6M+1.2%
Total assets$713M-2.1%
Total liabilities$177M+6.9%
Stockholders' equity$516M-3.1%
Gross: 65.8%Op.: -3.4%L/E: 0.34x

Frequently asked

Is BOSTON OMAHA Corp (BOC) a buy?
BOC currently carries a Sell rating with 2/5 conviction, derived from its latest SEC filings. Revenue grew 5.6% YoY; but unprofitable (net margin -10.9%).
What is BOSTON OMAHA Corp's quality score?
BOC scores 52.33333333333333/100 (grade C-) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001494582, latest 10-Q filed 2026-05-14) · EODHD · as of 6/26/2026, 7:53:07 PM.

Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC

Last 90 days: 7 open-market buys · 1 sale

2026-06-01
Kenan Frank H. II
Director
Buy6.03K @ $12.89$77.8K
2026-05-29
Kenan Frank H. II
Director
Buy10.0K @ $12.93$129K
2026-05-28
Kenan Frank H. II
Director
Buy34.7K @ $13.37$464K
2026-05-27
Royal Jeffrey C
Director
Buy10.0K @ $12.72$127K
2026-05-27
Royal Jeffrey C
Director
Buy10.0K @ $12.82$128K
2026-05-26
Royal Jeffrey C
Director
Buy11.0K @ $12.82$142K
2026-05-22
Royal Jeffrey C
Director
Buy10.0K @ $12.40$124K
2026-04-06
BOSTON OMAHA Corp
10% owner
Sell332K @ $9.05$3.00M
2026-02-12
Weisenburger Joshua Paul
Chief Financial Officer
Award4.06K @ $12.31$50.0K
2026-02-12
Weisenburger Joshua Paul
Chief Financial Officer
Tax742.00 @ $12.31$9.13K
2025-12-11
Burt Thomas
Director
Award14.7K @ $13.62$201K
2025-12-03
Kenan Frank H. II
Director
Award16.7K @ $12.94$217K

Earnings history

beat/miss · move
2026-05-14—▲ +3.21%8-K ↗
2025-11-13Miss -216.2% est▼ -0.81%8-K ↗
2025-08-13Miss -331.0% est▲ +0.88%8-K ↗
2025-05-14Miss -298.0% est▼ -0.65%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Recent news

market news →
A 45% Trim Inside a 12-Stock Fund Tells You More Than the Share CountBullish
finance.yahoo.com· 2026-04-29
Investment Manager Sells 67,000 Shares of Coal Stock, According to Recent SEC FilingBullish
finance.yahoo.com· 2026-04-27
Investment Manager Sells 67,000 Shares of Coal Stock, According to Recent SEC FilingBullish
nasdaq.com· 2026-04-27
Boston Omaha Looks Cheap on Paper, but Weak Management Could Keep It a Value TrapBearish
nasdaq.com· 2026-03-15
This Stock Used to Be My Largest Investment: Here's Why I Just Sold All My Shares Before the End of 2025Bullish
finance.yahoo.com· 2025-12-10
NYSE Content Advisory: Pre-Market Update + AeroMexico celebrates IPOBullish
finance.yahoo.com· 2025-11-25

Vs tracked universe

compare →

1043 tracked peers · median

EDGAR Score52 vs 67
Revenue growth5.6% vs 7.1%
Net margin-10.9% vs 10.5%
Return on equity-2.4% vs 12.3%
P/E— vs 25.5